American Chemical Society (ACS)
In Silico Pharmacophore Study and Structural Optimization of Nafamostat Yield Potentially Novel Transmembrane Protease Serine 2 (TMPRSS2) Inhibitors Which Block the Entry of SARS-CoV-2 Virus into Human Cells
Preprints
Nguyen, B
May 21, 2020
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Citation
APA
Chicago
ICMJE
MLA
NLM
Nguyen, B. (2020). In Silico Pharmacophore Study and Structural Optimization of Nafamostat Yield Potentially Novel Transmembrane Protease Serine 2 (TMPRSS2) Inhibitors Which Block the Entry of SARS-CoV-2 Virus into Human Cells. American Chemical Society (ACS). https://doi.org/10.26434/chemrxiv.12340001.v1
Nguyen, Bach. “In Silico Pharmacophore Study and Structural Optimization of Nafamostat Yield Potentially Novel Transmembrane Protease Serine 2 (TMPRSS2) Inhibitors Which Block the Entry of SARS-CoV-2 Virus into Human Cells.” American Chemical Society (ACS), May 21, 2020. https://doi.org/10.26434/chemrxiv.12340001.v1.
Nguyen, Bach. “In Silico Pharmacophore Study and Structural Optimization of Nafamostat Yield Potentially Novel Transmembrane Protease Serine 2 (TMPRSS2) Inhibitors Which Block the Entry of SARS-CoV-2 Virus into Human Cells.” American Chemical Society (ACS), 21 May 2020. Crossref, doi:10.26434/chemrxiv.12340001.v1.